Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States

Documenti analoghi

• Cost-effectiveness of Human Papillomavirus Vaccination in the United States
  di: Chesson, Harrell W., et al.
  Pubblicazione: (2008)
• Updated medical care cost estimates for HPV-associated cancers: implications for cost-effectiveness analyses of HPV vaccination in the United States
  di: Chesson, Harrell W., et al.
  Pubblicazione: (2019)
• The impact and cost-effectiveness of nonavalent HPV vaccination in the United States: Estimates from a simplified transmission model
  di: Chesson, Harrell W., et al.
  Pubblicazione: (2016)
• Estimates of the timing of reductions in genital warts and high grade cervical intraepithelial neoplasia after onset of human papillomavirus (HPV) vaccination in the United States
  di: Chesson, Harrell W., et al.
  Pubblicazione: (2013)
• The Estimated Impact of Human Papillomavirus Vaccine Coverage on the Lifetime Cervical Cancer Burden Among Girls Currently Aged 12 Years and Younger in the United States
  di: Chesson, Harrell W., et al.
  Pubblicazione: (2014)